Net income decreased 34.9%
Net income changed -34.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$4.7M→$3.0M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PDEX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 181.0%
Operating cash flow changed +181.0% from the comparable as-filed period.
$2.3M→$6.5M3 prior comparisons
Free-cash-flow proxy increased 177.8%
Free-cash-flow proxy changed +177.8% from the comparable as-filed period.
$2.2M→$6.1M0 prior comparisons
Gross margin moved 439 bp higher
Gross margin changed +439 basis points from the comparable as-filed period.
28.96%→33.35%3 prior comparisons
Inventory / revenue moved 986 bp lower
Inventory / revenue changed -986 basis points from the comparable as-filed period.
116.37%→106.51%3 prior comparisons
Working capital / assets moved 412 bp lower
Working capital / assets changed -412 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
57.73%→53.61%3 prior comparisons
Gross profit increased 27.8%
Gross profit changed +27.8% from the comparable as-filed period.
$5.4M→$6.9M3 prior comparisons
Research & development increased 57.6%
Research & development changed +57.6% from the comparable as-filed period.
$768,000→$1.2M3 prior comparisons
Operating income increased 13.1%
Operating income changed +13.1% from the comparable as-filed period.
$3.1M→$3.5M3 prior comparisons
Revenue increased 11.0%
Revenue changed +11.0% from the comparable as-filed period.
$18.5M→$20.6M3 prior comparisons
Total assets increased 19.1%
Total assets changed +19.1% from the comparable as-filed period.
$64.3M→$76.6M3 prior comparisons
Stockholders' equity increased 18.9%
Stockholders' equity changed +18.9% from the comparable as-filed period.
$41.5M→$49.3M2 prior comparisons
Capital expenditure increased 253.1%
Capital expenditure changed +253.1% from the comparable as-filed period.
$98,000→$346,0001 prior comparisons
Operating margin moved 32 bp higher
Operating margin changed +32 basis points from the comparable as-filed period.
16.78%→17.10%3 prior comparisons
Operating cash-flow margin moved 1910 bp higher
Operating cash-flow margin changed +1910 basis points from the comparable as-filed period.
12.47%→31.57%3 prior comparisons
Operating cash flow / net income increased 331.4%
Operating cash flow / net income changed +331.4% from the comparable as-filed period.
0.49→2.133 prior comparisons
Cash & equivalents changed across a low base
Cash & equivalents changed +35533.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$33,000→$11.8M3 prior comparisons
Receivables / revenue moved 1325 bp lower
Receivables / revenue changed -1325 basis points from the comparable as-filed period.
98.40%→85.15%3 prior comparisons
Free-cash-flow margin moved 1795 bp higher
Free-cash-flow margin changed +1795 basis points from the comparable as-filed period.
11.94%→29.88%0 prior comparisons
R&D / revenue moved 174 bp higher
R&D / revenue changed +174 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
4.14%→5.89%3 prior comparisons
Working capital increased 10.6%
Working capital changed +10.6% from the comparable as-filed period.
$37.1M→$41.1M3 prior comparisons
Current assets increased 6.4%
Current assets changed +6.4% from the comparable as-filed period.
$50.7M→$53.9M3 prior comparisons
Capex / revenue moved 115 bp higher
Capex / revenue changed +115 basis points from the comparable as-filed period.
0.53%→1.68%0 prior comparisons
Trade receivables decreased 4.0%
Trade receivables changed -4.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$18.2M→$17.5M3 prior comparisons
Shares outstanding decreased 1.9%
Shares outstanding changed -1.9% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
3,262,004→3,200,0018 prior comparisons
Current ratio increased 12.3%
Current ratio changed +12.3% from the comparable as-filed period.
3.73→4.193 prior comparisons
Stock-based compensation decreased 16.1%
Stock-based compensation changed -16.1% from the comparable as-filed period.
$161,000→$135,0003 prior comparisons
Cost of revenue increased 4.1%
Cost of revenue changed +4.1% from the comparable as-filed period.
$13.2M→$13.7M3 prior comparisons
Current liabilities decreased 5.3%
Current liabilities changed -5.3% from the comparable as-filed period.
$13.6M→$12.9M3 prior comparisons
SBC / revenue moved 21 bp lower
SBC / revenue changed -21 basis points from the comparable as-filed period.
0.87%→0.66%3 prior comparisons
Inventory increased 1.6%
Inventory changed +1.6% from the comparable as-filed period.
$21.6M→$21.9M3 prior comparisons
Operating margin moved 539 bp lower
Operating margin changed -539 basis points from the comparable as-filed period.
20.90%→15.51%1 prior comparisons
Free-cash-flow proxy increased 165.0%
Free-cash-flow proxy changed +165.0% from the comparable as-filed period.
$574,000→$1.5M0 prior comparisons
Operating cash flow increased 116.6%
Operating cash flow changed +116.6% from the comparable as-filed period.
$754,000→$1.6M1 prior comparisons
Gross margin moved 255 bp lower
Gross margin changed -255 basis points from the comparable as-filed period.
33.30%→30.74%1 prior comparisons
Working capital increased 23.6%
Working capital changed +23.6% from the comparable as-filed period.
$31.6M→$39.1M2 prior comparisons
Inventory / revenue moved 2249 bp lower
Inventory / revenue changed -2249 basis points from the comparable as-filed period.
134.56%→112.07%1 prior comparisons
Revenue increased 14.6%
Revenue changed +14.6% from the comparable as-filed period.
$17.4M→$19.9M1 prior comparisons
Net income increased 20.2%
Net income changed +20.2% from the comparable as-filed period.
$3.3M→$3.9M1 prior comparisons
Operating income decreased 15.0%
Operating income changed -15.0% from the comparable as-filed period.
$3.6M→$3.1M1 prior comparisons
Current ratio increased 34.6%
Current ratio changed +34.6% from the comparable as-filed period.
2.73→3.672 prior comparisons
Working capital / assets moved 291 bp higher
Working capital / assets changed +291 basis points from the comparable as-filed period.
49.21%→52.11%2 prior comparisons
Total assets increased 16.7%
Total assets changed +16.7% from the comparable as-filed period.
$64.3M→$75.0M2 prior comparisons
Trade receivables increased 22.8%
Trade receivables changed +22.8% from the comparable as-filed period.
$15.9M→$19.5M2 prior comparisons
Current liabilities decreased 20.1%
Current liabilities changed -20.1% from the comparable as-filed period.
$18.3M→$14.6M2 prior comparisons
Cost of revenue increased 18.9%
Cost of revenue changed +18.9% from the comparable as-filed period.
$11.6M→$13.8M1 prior comparisons
Capital expenditure decreased 37.8%
Capital expenditure changed -37.8% from the comparable as-filed period.
$180,000→$112,0001 prior comparisons
Cash & equivalents changed across a low base
Cash & equivalents changed +19981.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$33,000→$6.6M2 prior comparisons
Operating cash-flow margin moved 386 bp higher
Operating cash-flow margin changed +386 basis points from the comparable as-filed period.
4.33%→8.19%1 prior comparisons
Receivables / revenue moved 653 bp higher
Receivables / revenue changed +653 basis points from the comparable as-filed period.
91.08%→97.61%1 prior comparisons
Operating cash flow / net income increased 80.1%
Operating cash flow / net income changed +80.1% from the comparable as-filed period.
0.23→0.411 prior comparisons
Free-cash-flow margin moved 433 bp higher
Free-cash-flow margin changed +433 basis points from the comparable as-filed period.
3.30%→7.62%0 prior comparisons
Current assets increased 7.5%
Current assets changed +7.5% from the comparable as-filed period.
$49.9M→$53.7M2 prior comparisons
Inventory decreased 4.6%
Inventory changed -4.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$23.4M→$22.4M2 prior comparisons
Research & development decreased 12.7%
Research & development changed -12.7% from the comparable as-filed period.
$947,000→$827,0001 prior comparisons
Stock-based compensation increased 17.7%
Stock-based compensation changed +17.7% from the comparable as-filed period.
$158,000→$186,0001 prior comparisons
Capex / revenue moved 47 bp lower
Capex / revenue changed -47 basis points from the comparable as-filed period.
1.03%→0.56%0 prior comparisons
Shares outstanding decreased 2.1%
Shares outstanding changed -2.1% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
3,261,043→3,192,7597 prior comparisons
R&D / revenue moved 129 bp lower
R&D / revenue changed -129 basis points from the comparable as-filed period.
5.44%→4.15%1 prior comparisons
Gross profit increased 5.8%
Gross profit changed +5.8% from the comparable as-filed period.
$5.8M→$6.1M1 prior comparisons
SBC / revenue moved 3 bp higher
SBC / revenue changed +3 basis points from the comparable as-filed period.
0.91%→0.93%1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.